Developing Engineered CAR-Macrophages for Solid Tumor Immunotherapy

Time: 9:00 am
day: Day One


• Mapping the localization and migration of CAR-macrophages to determine concentrations at the tumor site

• Investigating the plasticity of engineered Macrophages and the persistence of cells and efficacy in vivo and drawing parallels with first in-patient data

• Sharing safety data and pharmacodynamic profiles of engineered macrophages

• Reflecting on interactions with regulators in bringing myeloid-derived cell therapies into the clinic with safety and efficacy data